Japan Securities Watchdog to Boost Monitoring of Biotech Stocks

  • SESC has noticed information leaks in the health industry
  • Will scrutinize trading when drug trial results are released

Japan’s securities watchdog will boost monitoring of health-care stocks for possible insider trading after noticing an increase in leaks of potentially market-moving information, according to the top official of the Securities and Exchange Surveillance Commission.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.